|
1
|
Chan XH, Nama S, Gopal F, Rizk P, Ramasamy
S, Sundaram G, et al: Targeting glioma stem cells by functional
inhibition of a prosurvival oncomiR-138 in malignant gliomas. Cell
Rep. 2:591–602. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang X, Yang H, Gong B, Jiang C and Yang
L: Combined gene expression and protein interaction analysis of
dynamic modularity in glioma prognosis. J Neurooncol. 107:281–288.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathupala SP, Mittal S, Guthikonda M and
Sloan AE: MicroRNA and brain tumors: a cause and a cure? DNA Cell
Biol. 26:301–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fu H, Hu ZL, Wen JF, Wang KS and Liu Y:
TGF-β promotes invasion and metastasis of gastric cancer cells by
increasing fascin1 expression via ERK and JNK signal pathways. Acta
Biochim Biophys Sin (Shanghai). 41:648–656. 2009.
|
|
5
|
Kaminska B, Kocyk M and Kijewska M: TGF
beta signaling and its role in glioma pathogenesis. Adv Exp Med
Biol. 986:171–187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Connolly EC, Freimuth J and Akhurst RJ:
Complexities of TGF-β targeted cancer therapy. Int J Biol Sci.
8:964–978. 2012.
|
|
7
|
Nicoloso MS and Calin GA: MicroRNA
involvement in brain tumors: from bench to bedside. Brain Pathol.
18:122–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gaur A, Jewell DA, Liang Y, Ridzon D,
Moore JH, Chen C, Ambros VR and Israel MA: Characterization of
microRNA expression levels and their biological correlates in human
cancer cell lines. Cancer Res. 67:2456–2468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pang JC, Kwok WK, Chen Z and Ng HK:
Oncogenic role of microRNAs in brain tumors. Acta Neuropathol.
117:599–611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mansfield JH, Harfe BD, Nissen R, Obenauer
J, Srineel J, Chaudhuri A, et al: MicroRNA-responsive ‘sensor’
transgenes uncover Hox-like and other developmentally regulated
patterns of vertebrate microRNA expression. Nat Genet.
36:1079–1083. 2004.
|
|
12
|
Garzon R, Pichiorri F, Palumbo T, Iuliano
R, Cimmino A, Aqeilan R, et al: MicroRNA fingerprints during human
megakaryocytopoiesis. Proc Natl Acad Sci USA. 103:5078–5083. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan Y, Luo YC, Wan HY, et al: MicroRNA-10a
is involved in the metastatic process by regulating Eph tyrosine
kinase receptor A4-mediated epithelial-mesenchymal transition and
adhesion in hepatoma cells. Hepatology. 57:667–677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weiss FU, Marques IJ, Woltering JM,
Vlecken DH, Aghdassi A, Partecke LI, et al: Retinoic acid receptor
antagonists inhibit miR-10a expression and block metastatic
behaviour of pancreatic cancer. Gastroenterology. 137:2136–2145.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008.PubMed/NCBI
|
|
16
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–60.
2012.PubMed/NCBI
|
|
18
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasayama T, Nishihara M, Kondoh T, Hosoda
K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma
and associated with tumor invasive factors, uPAR and RhoC. Int J
Cancer. 125:1407–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garzon R, Garofalo M, Martelli MP,
Briesewitz R, Wang L, Fernandez-Cymering C, et al: Distinctive
microRNA signature of acute myeloid leukemia bearing cytoplasmic
mutated nucleophosmin. Proc Natl Acad Sci USA. 105:3945–3950. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lund AH: miR-10 in development and cancer.
Cell Death Differ. 17:209–214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takahashi H, Kanno T, Nakayamada S,
Hirahara K, Sciumè G, Muljo SA, et al: TGF-β and retinoic acid
induce the microRNA miR-10a, which targets Bcl-6 and constrains the
plasticity of helper T cells. Nat Immunol. 13:587–595. 2012.
|
|
23
|
Luo H, Yang Y, Duan J, Wu P, Jiang Q and
Xu C: PTEN-regulated AKT/FoxO3a/Bim signaling contributes to
reactive oxygen species-mediated apoptosis in selenite-treated
colorectal cancer cells. Cell Death Dis. 4:e4812013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wakefield LM, Letterio JJ, Chen T,
Danielpour D, Allison RS, Pai LH, Denicoff AM, Noone MH, Cowan KH,
O’Shaughnessy JA, et al: Transforming growth factor-beta1
circulates in normal human plasma and is unchanged in advanced
metastatic breast cancer. Clin Cancer Res. 1:129–136.
1995.PubMed/NCBI
|
|
25
|
Patel RR and Mehta MP: Targeted therapy
for brain metastases: improving the therapeutic ratio. Clin Cancer
Res. 13:1675–1683. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heldin CH, Vanlandewijck M and Moustakas
A: Regulation of EMT by TGF-β in cancer. FEBS Letters.
586:1959–1970. 2012.
|
|
27
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghosal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chung AC, Huang XR, Meng X and Lan HY:
miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc
Nephrol. 21:1317–1325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dey N, Ghosh-Choudhury N, Kasinath BS and
Choudhury GG: TGFβ-stimulated microRNA-21 utilizes PTEN to
orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and
matrix expansion. PLoS One. 7:e423162012.
|
|
30
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chai G, Liu N, Ma J, Li H, Oblinger JL,
Prahalad AK, et al: MicroRNA-10b regulates tumorigenesis in
neurofibromatosis type 1. Cancer Sci. 101:1997–2004. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026.
2012.PubMed/NCBI
|
|
33
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
